Article
Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutation.
American journal of clinical pathology - 19 Nov 2025
Segura Rossana N Lazcano, Nardi Valentina, Hoang Mai P
Abstract excerpt
OBJECTIVE: The role of NPM1 immunostaining as a surrogate marker for acute myeloid leukemia (AML) with nucleophosmin (NPM1) mutation (AML-NPM1) in leukemia cutis has not been investigated. METHODS: NPM1 immunostaining was performed using a polyclonal antibody on leukemia cutis diagnosed in 2017-2024 of 15 patients with and 15 without the NPM1 mutation. Targeted next-generation sequencing assays were performed on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
